Literature DB >> 14976400

Monochorionic triplets following intracytoplasmic sperm injection: a report of two consecutive cases.

Ulun Ulug1, Esra Aksoy Jozwiak, Ali Mesut, Faruk Bener, Mustafa Bahceci.   

Abstract

Monochorionic triplet pregnancies are very rare. Here we report 2 cases of multiple pregnancies with monochorionic triplets following intracytoplasmic sperm injection (ICSI) and day 3 embryo transfer. The 2 women concomitantly underwent controlled ovarian hyperstimulation due to male factor infertility. Following oocyte retrieval, ICSI and assisted hatching (AH) were performed, and the 2 women conceived consecutively. One patient had a quadruplet pregnancy, which included monochorionic triplets, while the other had monochorionic triplets. Selective embryo reduction by intracardiac KCl injection targeted at 2 of the triplets was performed on the patient with the quadruplet pregnancy, but the third triplet also died. The gestation continued as a singleton pregnancy, and the patient gave birth to a healthy female baby at 38 weeks. The other patient gave birth to 3 healthy female babies at 34 weeks. Possible etiologic factors for the formation of monozygotic splitting among women undergoing assisted reproduction treatment are discussed. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 14976400     DOI: 10.1159/000076786

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  2 in total

1.  Monochorionic triamniotic triplet pregnancy with a co-triplet fetus discordant for congenital cystic adenomatoid malformation of the lung.

Authors:  Ahmet Gul; Halil Aslan; Altan Cebeci; Yavuz Ceylan; Ali Ismet Tekirdag
Journal:  Reprod Health       Date:  2005-04-08       Impact factor: 3.223

2.  Dichorionic quadruplet pregnancy comprising monozygotic triplets and singleton after intracytoplasmic sperm injection and transfer of two fresh embryos: a case report.

Authors:  Ying Nie; Xiaoyong Qiao; Sicong Li; Zhuo Pan; Jing Zhang; Liangzhi Xu
Journal:  J Int Med Res       Date:  2022-02       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.